ESR1 and breast carcinoma: Li et al28 demonstrated that IKBKE interacted with ER‐α36 (estrogen receptor‐α), a novel variant of ER‐α, and increased its expression in breast cancer cells, enhancing ER‐α36‐mediated mitogenic and nongenomic estrogen signaling.